CDH3 Gene Ectodermal Dysplasia Ectrodactyly and Macular Dystrophy Genetic Test
Test Name: CDH3 Gene Ectodermal dysplasia ectrodactyly and macular dystrophy Genetic Test
Components: NGS Technology
Price: 4400.0 AED
Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery: 3 to 4 Weeks
Test Type: Osteology Dermatology Immunology Disorders
Doctor: Dermatologist
Test Department: Genetics
Pre Test Information: Clinical History of Patient who is going for CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test gene CDH3
Test Details
The CDH3 gene is associated with a condition called ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM) syndrome. This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the CDH3 gene to identify any mutations or variations that may be causing the EEM syndrome.
Ectodermal dysplasia refers to a group of genetic disorders that primarily affect the development of the ectodermal tissues, which include the skin, hair, nails, teeth, and sweat glands. Ectrodactyly, also known as split hand/foot malformation, is a condition characterized by missing or underdeveloped fingers or toes. Macular dystrophy is a progressive eye disorder that affects the macula, the central part of the retina responsible for sharp, central vision.
By performing an NGS genetic test on the CDH3 gene, healthcare professionals can identify specific mutations or variations in the gene that are associated with EEM syndrome. This information can help in diagnosing individuals with EEM syndrome, providing genetic counseling to affected individuals and their families, and potentially guiding treatment options or interventions.
| Test Name | CDH3 Gene Ectodermal dysplasia ectrodactyly and macular dystrophy Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CDH3 Gene Ectodermal dysplasia, ectrodactyly, and macular dystrophy NGS Genetic DNA Test gene CDH3 |
| Test Details |
The CDH3 gene is associated with a condition called ectodermal dysplasia, ectrodactyly, and macular dystrophy (EEM) syndrome. This genetic test, known as NGS (Next-Generation Sequencing), is used to analyze the DNA sequence of the CDH3 gene to identify any mutations or variations that may be causing the EEM syndrome. Ectodermal dysplasia refers to a group of genetic disorders that primarily affect the development of the ectodermal tissues, which include the skin, hair, nails, teeth, and sweat glands. Ectrodactyly, also known as split hand/foot malformation, is a condition characterized by missing or underdeveloped fingers or toes. Macular dystrophy is a progressive eye disorder that affects the macula, the central part of the retina responsible for sharp, central vision. By performing an NGS genetic test on the CDH3 gene, healthcare professionals can identify specific mutations or variations in the gene that are associated with EEM syndrome. This information can help in diagnosing individuals with EEM syndrome, providing genetic counseling to affected individuals and their families, and potentially guiding treatment options or interventions. |
